How Much Does Semaglutide Cost in 2026?

Brand-name semaglutide is manufactured by Novo Nordisk and sold under two primary brand names:

• Ozempic (for type 2 diabetes) — $800 to $1,200 per month without insurance
• Wegovy (for weight management) — $1,000 to $1,500 per month without insurance

Insurance coverage varies significantly:

• Commercial insurance — Many plans cover Ozempic for diabetes with copays of $25-150/month. Wegovy coverage for weight loss is less common and more restrictive.
• Medicare — Part D plans may cover Ozempic for diabetes. Weight loss coverage under Medicare has expanded but remains limited.
• No insurance — Full retail price applies. Novo Nordisk offers savings cards that may reduce costs for eligible commercially insured patients.

The list price of brand-name semaglutide has been a subject of significant public debate, with many patients unable to access the medication due to cost alone.

Compounded semaglutide offers a substantially more affordable alternative:

• Telehealth + compounding programs — $200 to $400 per month, including consultation and medication
• Compounding pharmacy direct — $150 to $350 per month with a valid prescription
• Subscription programs — Some providers offer $175-300/month with multi-month commitments

Compounded pricing includes the medication but may or may not include:

• Initial telehealth consultation ($50-150 one-time)
• Follow-up appointments ($0-75 per visit)
• Required lab work ($0-200, varies by provider)
• Shipping and handling ($0-15 per shipment)

When comparing compounded options, always calculate the total all-in monthly cost rather than just the medication price.

Research peptide vendors offer semaglutide for laboratory research purposes at significantly lower price points:

• 5mg vial — $30 to $50 from reputable vendors
• 10mg vial — $50 to $80 from reputable vendors

Research-grade semaglutide is sold strictly for in vitro and laboratory research purposes. It is not intended for human use and is not manufactured under pharmaceutical-grade cGMP conditions in most cases.

When purchasing research-grade semaglutide, quality varies considerably between vendors. Key factors that affect pricing include:

• Purity level (98%+ vs 99%+)
• Third-party testing and COA availability
• Vendor reputation and track record
• Order volume and bulk discounts

Research peptides are not approved for human consumption. This pricing information is provided for researchers conducting legitimate scientific investigations.

Several strategies can help reduce the cost of semaglutide:

• Check insurance formulary — Contact your insurer directly to understand coverage, tier placement, and any step therapy requirements.
• Manufacturer savings programs — Novo Nordisk offers savings cards for commercially insured patients that can reduce copays significantly.
• Patient assistance programs — Qualifying low-income patients may access brand-name semaglutide at reduced or no cost through Novo Nordisk’s PAP.
• Compare telehealth providers — Pricing for compounded semaglutide varies widely between telehealth platforms. Compare at least 3-4 providers.
• Ask about dose optimization — Some providers offer lower starting doses at reduced prices, allowing gradual titration.

Always consult a healthcare provider before starting semaglutide. This article is for informational purposes only and does not constitute medical or financial advice.